Project Factsheets

Displaying 90 projects

ABIRISK

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk
Ongoing | IMI1 |
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk

ADAPT-SMART

Accelerated development of appropriate patient therapies: a sustainable, multi-stakeholder approach from research to treatment-outcomes
Ongoing | IMI2 |
ADAPT-SMART logo

ADVANCE

Accelerated development of vaccine benefit-risk collaboration in Europe
Ongoing | IMI1 |

CANCER-ID

Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
Ongoing | IMI1 |
CANCER-ID logo

DIRECT

Diabetes research on patient stratification
Ongoing | IMI1 |
Diabetes research on patient stratification

EBiSC

European Bank for induced pluripotent Stem Cells
Ongoing | IMI1 |

eTOX

Integrating bioinformatics and chemoinformatics approaches for the development of Expert systems allowing the in silico prediction of toxicities
Ongoing | IMI1 |
Integrating bioinformatics and chemoinformatics approaches for the development o

EU-AIMS

European Autism Interventions - a Multicentre Study for Developing New Medications
Ongoing | IMI1 |
European Autism Interventions - a Multicentre Study for Developing New Medicatio

HARMONY

Healthcare alliance for resourceful medicines offensive against neoplasms in hematology
Ongoing | IMI2 |
HARMONY logo

IMIDIA

Improving beta-cell function and identification of diagnostic biomarkers For treatment monitoring in diabetes
Ongoing | IMI1 |
Improving beta-cell function and identification of diagnostic biomarkers For tre

iPiE

Intelligent Assessment of Pharmaceuticals in the Environment
Ongoing | IMI1 |
iPiE project logo

MARCAR

Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
Closed | IMI1 |
Surrogate markers for micro- and macro-vascular hard endpoints For innovative di

MIP-DILI

Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury
Ongoing | IMI1 |
Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Inju

Onco Track

Methods for systematic next generation oncology biomarker development
Ongoing | IMI1 |
METHODS FOR SYSTEMATIC NEXT GENERATION ONCOLOGY BIOMARKER DEVELOPMENT SUMMARY

Pharma-Cog

Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
Closed | IMI1 |
project logo

PRECISESADS

Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases
Ongoing | IMI1 |
PRECISESADS project logo

Predect

New models for preclinical evaluation of drug efficacy in common solid tumours

Ongoing | IMI1 |
Prediction of cognitive properties of new drug candidates For neurodegenerative

PreDiCT-TB

Model-based preclinical development of anti-tuberculosis drug combinations
Ongoing | IMI1 |
Model-based preclinical development of anti-tuberculosis drug combinations

PREFER

Patient Preferences in benefit risk assessments during the drug life cycle
Ongoing | IMI2 |
PREFER

PROTECT

Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
Ongoing | IMI1 |
Pharmacoepidemiological research on outcomes of therapeutics by a European consortium

Quic-Concept

Quantative imaging in cancer:connecting cellular process with therapy
Ongoing | IMI1 |
QUANTITIVE IMAGING IN CANCER: CONNECTING CELLULAR PROCESSES WITH THERAPY

RADAR-CNS

Remote Assessment of Disease and Relapse in Central Nervous System Disorders
Ongoing | IMI2 |
RADAR-CNS logo

RHAPSODY

Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification
Ongoing | IMI2 |
RHAPSODY logo

SAFE-T

Safer and Faster Evidence-based Translation
Ongoing | IMI1 |
Safer and Faster Evidence-based Translation

SUMMIT

Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
Closed | IMI1 |
Surrogate markers for micro- and macro-vascular hard endpoints For innovative di

TransQST

Translational quantitative systems toxicology to improve the understanding of the safety of medicines
Ongoing | IMI2 |
TransQST logo

TRISTAN

Imaging biomarkers (IBs) for safer drugs: validation of translational imaging methods in drug safety assessment
Ongoing | IMI2 |

U-BIOPRED

Unbiased biomarkers for the prediction of respiratory disease outcomes
Closed | IMI1 |
Unbiased biomarkers for the prediction of respiratory disease outcomes

VAC2VAC

Vaccine lot to vaccine lot comparison by consistency testing
Ongoing | IMI2 |